May 2, 2017 / 11:15 AM / 3 months ago

BRIEF-Concert Pharmaceuticals Q1 loss $0.60/shr

1 Min Read

May 2 (Reuters) - Concert Pharmaceuticals Inc

* Concert pharmaceuticals reports first quarter 2017 financial results

* Q1 loss per share $0.60

* Q1 earnings per share view $-0.59 -- Thomson Reuters I/B/E/S

* Concert pharmaceuticals- cash, cash equivalents,investments as of march 31, 2017, totaled $83.9 million as compared to $96.2 million as of december 31, 2016

* Concert pharmaceuticals - expects its cash, cash equivalents and investments as of march 31, 2017 to be sufficient to fund company through q2 of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below